Diagnosticum Center for Human Genetics

Personnel

Director: Daniela Steinberger, MD, Medical Director
Phone: +49 695308437-0
Fax: +49 695308437-11
Email: cs@genetik.diagnosticum.eu
Jutta Trübenbach, MSc, Quality Management
Phone: +49 69 53084370
Fax: +49 69 530843711
Email: qm@genetik.diagnosticum.eu

Conditions and tests

57 conditions/phenotypes with 2 tests
Enter text to narrow down the list

Alcohol dependence1 test
Alcohol sensitivity, acute1 test
Amitriptyline response1 test
Anemia, nonspherocytic hemolytic, due to G6PD deficiency1 test
Angiotensin i-converting enzyme, benign serum increase1 test
Beta-2-adrenoreceptor agonist, reduced response to1 test
Capecitabine response1 test
Catechol-o-methyltransferase deficiency1 test
Citalopram response1 test
Clopidogrel response2 tests
Codeine response1 test
Colchicine resistance1 test
CYP2C19-related poor drug metabolism2 tests
Deficiency of butyrylcholinesterase1 test
Dihydropyrimidine dehydrogenase deficiency2 tests
Disorder due cytochrome p450 CYP1A21 test
Disorder due cytochrome p450 CYP2C19 variant1 test
Disorder due cytochrome p450 CYP2C9 variant1 test
Disorder due cytochrome p450 CYP2D6 variant2 tests
Doxepin response1 test
Efavirenz response1 test
Escitalopram response1 test
Esomeprazole response1 test
Essential hypertension1 test
Fluoropyrimidine response1 test
Fluorouracil response1 test
Fluvoxamine response1 test
Glycogen storage disease1 test
Hepatitis C virus, susceptibility to1 test
Hereditary thrombophilia1 test
Homocystinuria due to methylene tetrahydrofolate reductase deficiency2 tests
Inherited susceptibility to asthma1 test
Irinotecan response1 test
Malaria, susceptibility to1 test
Mercaptopurine response1 test
Microvascular complications of diabetes, susceptibility to, 51 test
Microvascular complications of diabetes, susceptibility to, 61 test
Nortriptyline response1 test
Obesity1 test
Paroxetine response1 test
Pseudocholinesterase deficiency1 test
Selective serotonin reuptake inhibitor response1 test
Sertraline response1 test
Simvastatin response1 test
Slow acetylator due to N-acetyltransferase enzyme variant2 tests
Statin-induced myopathy1 test
Tacrolimus response1 test
Tamoxifen response1 test
Tegafur response1 test
Thioguanine response1 test
Thiopurine S-methyltransferase deficiency1 test
Thrombophilia due to activated protein C resistance1 test
Thrombophilia due to thrombin defect2 tests
Tobacco addiction, susceptibility to1 test
Ubiquitous Glucose-6-Phosphatase Deficiency1 test
Vitamin K-dependent clotting factors, combined deficiency of, type 21 test
Warfarin response1 test

List of services

Clinical Testing/Confirmation of Mutations Identified Previously
Confirmation of research findings
Custom Balanced Chromosome Rearrangement Studies
Custom Deletion/Duplication Testing
Prenatal testing
Custom Sequence Analysis
Custom microarray analysis
Carrier testing
Genetic counseling
Marker Chromosome Identification
Maternal cell contamination study (MCC)
Mutation Confirmation
Result interpretation
Uniparental Disomy (UPD) Testing
Whole Exome Sequencing
Clinical exome, comments
4.500 - 4.800 genes

List of certifications/licenses

Certifications

CAP, Number: 7234132, Expiration date: 2013-01-17
CAP, Number: 7234132, Expiration date: 2015-01-17
CAP, Number: 7234132, Expiration date: 2017-01-17
CAP, Number: 7234132, Expiration date: 2019-01-17
CAP, Number: 7234132, Expiration date: 2021-01-17

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.